CFLAR and non-small cell lung carcinoma: More recently it was reported that cFLIPS, a shorter isoform of cFLIP, is strongly upregulated in surviving non-small cell lung carcinomas (NSCLC) in response to chemotherapy, promoting TRAIL resistance.